Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Tempest Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 22 | 24 | +2 |
| Shares | 3.83M | 3.41M | −415.7K (−10.9%) |
| Value | $4.86M | $1.05M | −$3.81M (−78.4%) |
New holders (5)
Institutions that held Tempest Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 44,882 | $14.0K | 0.00% |
| HRT Financial LP | 29,948 | $9.00K | 0.00% |
| Virtu Financial LLC | 25,337 | $8.00K | 0.00% |
| Qube Research & Technologies Ltd | 27 | $8 | 0.00% |
| JPMorgan Chase & Co | 6 | $2 | 0.00% |
Sold out (3)
Institutions that held Tempest Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Sectoral Asset Management Inc | 219,394 | $278.6K |
| UBS Group AG | 800 | $1.02K |
| Advisor Group Holdings, Inc. | 100 | $127 |